Is CL Stock Undervalued?

A comprehensive valuation analysis of Colgate-Palmolive Company (CL) examining current multiples, intrinsic value, and comparing to analyst expectations.

Updated June 8, 2026•8 min read•View Full Analysis

Valuation Verdict

→

Fairly Valued

0.0% downside risk

Based on our analysis, Colgate-Palmolive Company appears to be fairly valued at the current price of $0.00. Our fair value estimate of $32381988883.96 suggests downside risk of approximately 0.0%.

Current Valuation Metrics

Valuation ratios help us understand how the market is pricing CL relative to its fundamentals. Let's examine the key multiples investors are paying today.

P/E Ratio

34.33

High

P/B Ratio

N/A

P/S Ratio

N/A

EV/EBITDA

N/A

Understanding the Metrics

P/E Ratio: At 34.33x earnings, CL is trading above the typical market average of 15-20x.
P/B Ratio: Book value data not available.
P/S Ratio: Revenue data not available.
EV/EBITDA: EBITDA data not available.

Fair Value Estimate

Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Colgate-Palmolive Company stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.

Current Price

$0.00

Fair Value Estimate

$32381988883.96

Implied Return0.0%

CL appears fairly valued, trading within 15% of our intrinsic value estimate. The market price closely reflects the fundamental value we calculate.

Investment Conclusion

Bottom Line

Colgate-Palmolive Company (CL) appears fairly valued at $0.00, trading in line with our fundamental analysis. The stock may be appropriate for investors seeking exposure to Consumer Defensive without significant valuation risk.

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.